A win in the most important category: Best Patient Impact of the Year.This is just the tip of the iceberg. Over the past year, we’ve worked incredibly hard to bring our vision to life — and the progress we’ve made is something we’re truly proud of. What you don’t see behind closed doors is the
20 patients have now been implanted with the TIES® device in our pivotal clinical trial OstomySecure has successfully completed a crucial patient recruitment milestone in its pivotal clinical trial of the company’s TIES implant technology. 20 patients have now been implanted with the device with participating hospitals in the UK, Sweden, Poland, Austria, and India.
We are delighted to announce that our clinical trial for our TIES implant has now been initiated at hospitals in the UK, Sweden, Poland, Austria and India.
Fantastic to welcome Professor Manish Chand, Consultant Colorectal Surgeon & Professor of Surgery at University College London, to the clinical evaluation of our TIES® implant
In today’s Europe of stricter safety and regulatory protocols, we are committed to do whatever it takes to bring the lifestyle changing TIES solution to as many people as possible”.
OstomySecure has moved its Stockholm operations from Kista to the Karolinska Campus area in Solna in the heart of the bustling Stockholm life science scene.
Today, the first patient was enrolled in the TIES03 study of the Ostom Cure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications. “We see the TIES® Solution as a potential step change for ileostomy patients, providing them with a better quality of life,” said Prof. David Jayne,
We are pleased to announce that Professor David Jayne and his team at Leeds Teaching Hospital NHS Trust in the UK have joined our clinical trial to evaluate our TIES® implant.
OstomySecure AS has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.(https://ec.europa.eu/programmes/horizon2020/what-horizon-2020). “This EU grant is a major milestone for OstomySecure AS, and further confirms the very unique benefits of TIES Solution which are now endorsed by a very capable public institution” – Says Dr. Ben Broennimann, CEO of OstomySecure AS
